PERIOPERATIVE PROGNOSTIC FACTORS FOR FONTAN PATIENTS UNDERGOING ORTHOTOPIC HEART TRANSPLANT  by Berg, Christopher et al.
Congenital Heart Disease
A516
JACC March 17, 2015
Volume 65, Issue 10S
perioperative prognostiC faCtors for fontan patients undergoing orthotopiC 
heart transplant
Poster Contributions
Poster Hall B1
Saturday, March 14, 2015, 10:00 a.m.-10:45 a.m.
Session Title: Clinical Outcomes in Single Ventricle Patients
Abstract Category: 12.  Congenital Heart Disease: Therapy
Presentation Number: 1118-326
Authors: Christopher Berg, Brenton Bauer, Abbie Hageman, Leigh Reardon, David Geffen School of Medicine at UCLA, Los Angeles, CA, 
USA, Ahmanson/UCLA Adult Congenital Heart Disease Center, Los Angeles, CA, USA
Background:  Although the Fontan procedure offers a long-term palliative option for single-ventricle patients, orthotopic heart 
transplantation (OHT) remains the definitive treatment for a failing Fontan circuit. We hypothesized that there are a set of perioperative 
variables associated with increased risk of postoperative adverse outcomes.
methods:  36 post-Fontan patients were identified as having undergone OHT at UCLA Medical Center from 1991 to 2014. Data was 
collected retrospectively and analyzed. The primary endpoint was designated as either: perioperative mortality, extended postoperative 
hospital stay (>30 days), or readmission within 2 weeks of discharge.
results:  17 of 36 patients reached the primary endpoint; 8 patients suffered perioperative death after OHT, 6 patients experienced 
extended hospital stays, and 4 patients were readmitted within 2 weeks after discharge. Of the patients that suffered the primary outcome, 
11 of these patients had an extended preoperative hospital stay (>10 days), 7 patients had an elevated MELD-XI score (≥18), and 8 
patients had an extended perioperative cardiopulmonary bypass time (>4 hours). Patients with an elevated MELD-XI score (p=0.0128) 
or an extended cardiopulmonary bypass time (p=0.0002) carried a significantly higher risk of reaching the primary endpoint. A composite 
scoring system of eight criteria was used to stratify the risk of patients suffering the primary endpoint. Patients with scores of ≥3, 2, and 0-1 
had a 91.1%, 33.3%, and 25% risk of reaching the primary endpoint, respectively. Patients with a score of ≥3 had a relative risk of 3.6 over 
patients with 0-1 points (95% CI, 1.53-8.67; p=0.0013).
Conclusion:  Failing Fontan patients undergoing OHT with elevated preoperative MELD-XI scores and/or extended perioperative 
cardiopulmonary bypass times are at greater risk of experiencing adverse outcomes after transplant. Additionally, a novel scoring system 
was devised for optimized risk stratification of suffering an adverse outcome after OHT, in which a score of ≥3 was predictive of poorer 
outcomes. This scoring system may allow for potential improvements in recipient evaluation during the listing process.
